Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





World's First Patient-Controlled Nasopharyngeal Swab Robot for COVID-19 Testing Reduces Risk of Exposure to SARS-CoV-2

By LabMedica International staff writers
Posted on 23 Sep 2020
A new robot for automated COVID-19 swab test could provide a solution to protect and reduce the risk of exposure faced by healthcare workers to the SARS-CoV-2 virus.

Biobot Surgical Pte Ltd (Singapore) has developed the SwabBot, a robot for automated swab, to address the challenges of COVID-19 swab test. More...
In addition to protecting and reducing the healthcare workers’ risk of exposure to the novel coronavirus, it also standardizes the consistency of swabs taken while providing greater throughput of swab tests.

The SwabBot is a robot which allows individuals to self-administer the swabbing process. By pushing the chin and face forward against activation button, it activates the robot which gently inserts a swab stick through the nose to the back of the nasal cavity. The duration of the swab takes only 20 seconds. To ensure the safety of the individual, the robot has a built-in feature which retracts the swab stick if there is resistance in moving deeper into the nasal cavity.

“When we developed the SwabBot, we envisaged a self swabbing device that could be deployed and used, similar to how self check-out systems are now prevalent in the supermarkets. This should be especially effective for rostered routine testing and reduce manpower involved in swabbing operations,” said Mr. Sim Kok Hwee, CEO of Biobot Surgical.

Related Links:
Biobot Surgical Pte Ltd


Platinum Member
Fully Automatic ACLIA Analyzer
MAGLUMI X8
Gold Member
SARS-CoV-2 PCR Test
Macurra SARS-CoV-2 PCR Kit
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: TRUECAM automatically eliminates ambiguous or uninformative regions in whole-slide pathology images, enhancing the reliability of diagnostic analysis. (Photo courtesy of PolyU)

AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis

Ensuring reliable cancer diagnosis from digital pathology remains a critical challenge as clinical decisions rely on accurate slide interpretation. While artificial intelligence (AI) has accelerated whole-slide... Read more

Industry

view channel
Image Credit: Adobe Stock

Global Urinalysis Market Gowth Driven by Demand for Automated and POC Testing

Urinalysis is a widely used diagnostic method for detecting urinary tract infections, kidney and liver diseases, diabetes, and other conditions through urine sample analysis. These tests support early... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.